Viewing Study NCT04958967


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT04958967
Status: WITHDRAWN
Last Update Posted: 2025-03-14
First Post: 2021-07-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase Ib Study of FURMONERTINIB in Patients with NSCLC Having Exon 20 Insertion Mutation
Sponsor: Allist Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module